Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.61 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | LCK | P06239 | 1/20 | 0.46 |
| ▸ | PPARD | Q03181 | 1/20 | 0.46 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.46 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.43 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.43 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6847294 | 1.00 | GPR84 (0.61) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL1478514 | 1.00 | GPR84 (0.61) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL353157 | 1.00 | GPR84 (0.61) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL354538 | 1.00 | GPR84 (0.61) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL353979 | 1.00 | GPR84 (0.61) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL2230358 | 1.00 | GPR84 (0.61) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL7617823 | 1.00 | GPR84 (0.61) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL9285129 | 1.00 | GPR84 (0.61) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL6030962 | 0.98 | GPR84 (0.59) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL3634598 | 0.97 | GPR84 (0.58) | GPR84FFAR1MAPTLCKPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120093737-A1 | LIGHT-ABSORBING COMPOSITIONS AND METHODS OF USE | ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS, INC. | 2012-04-19 | — | — | US | disclosed |
| US-20120076842-A1 | COSMETIC USE OF TYR-ARG DIPEPTIDE TO COMBAT CUTANEOUS SAGGING | SEDERMA (FR) | 2012-03-29 | — | — | US | disclosed |
| EP-2419076-A2 | COSMETIC COMPOSITIONS COMPRISING ORIDONIN AND NEW COSMETIC USES | Sederma (FR) | 2012-02-22 | — | — | EP | disclosed |
| US-20120028916-A1 | COSMETIC COMPOSITIONS COMPRISING ORIDONIN AND NEW COSMETIC USES | SEDERMA (FR) | 2012-02-02 | — | — | US | disclosed |
| US-20120014887-A1 | NEW COMPOUNDS, IN PARTICULAR PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMO-PHARMACEUTICAL USES | SEDERMA (FR) | 2012-01-19 | — | — | US | disclosed |
| EP-2382231-A2 | NEW COMPOUNDS, IN PARTICULAR PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMOPHARMACEUTICAL USES | Sederma (FR) | 2011-11-02 | — | — | EP | disclosed |
| EP-2382230-A2 | KXK-PEPTIDE COMPOSITIONS FOR COSMETIC AND DERMO-PHARMACEUTIC USES | Sederma (FR) | 2011-11-02 | — | — | EP | disclosed |
| US-20110250276-A1 | Cosmetic Composition Containing Acetylated Oligoglucuronans | SEDERMA, S.A.S. (FR) | 2011-10-13 | — | — | US | disclosed |
| EP-2367852-A1 | COSMETIC COMPOSITION CONTAINING ACETYLATED OLIGOGLUCURONANS | Sederma (FR) | 2011-09-28 | — | — | EP | disclosed |
| EP-2046283-B1 | COMPOSITION COMPRISING SARSASAPOGENIN | SEDERMA SA (FR) | 2011-03-16 | — | — | EP | disclosed |
| US-20110045036-A1 | Cosmetic Compositions Comprising at Least One Peptide with at Least One Immobilized Aromatic Cycle | SEDERMA (FR) | 2011-02-24 | — | — | US | disclosed |
| US-20110033507-A1 | Polypeptides KXK and Their Use | SEDERMA (FR) | 2011-02-10 | — | — | US | disclosed |
| US-20110002865-A1 | MOISTURIZING COSMETIC COMPOSITION COMPRISING A COMBINATION OF HOMARINE AND ERYTHRITOL | SEDERMA, S.A.S. (FR) | 2011-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120014887-A1 | NEW COMPOUNDS, IN PARTICULAR PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMO-PHARMACEUTICAL USES | CUTA, PLOD3, MC1R | GPR84 836/4885FFAR1 1453/4885MAPT 4321/4885 |
| US-20110033507-A1 | Polypeptides KXK and Their Use | NPR3, NGLY1, NPR1 | GPR84 627/4885FFAR1 1527/4885MAPT 4608/4885 |
| US-20120076842-A1 | COSMETIC USE OF TYR-ARG DIPEPTIDE TO COMBAT CUTANEOUS SAGGING | ARGLU1, CUTA, ARG1 | GPR84 300/4885FFAR1 1033/4885MAPT 4502/4885 |
| US-20110045036-A1 | Cosmetic Compositions Comprising at Least One Peptide with at Least One Immobilized Aromatic Cycle | TYR, XPA, MC1R | GPR84 2207/4885FFAR1 3605/4885MAPT 3119/4885 |
| US-20110002865-A1 | MOISTURIZING COSMETIC COMPOSITION COMPRISING A COMBINATION OF HOMARINE AND ERYTHRITOL | AQP1, CUTA, AQP3 | GPR84 1922/4885FFAR1 2540/4885MAPT 2687/4885 |
| US-20110250276-A1 | Cosmetic Composition Containing Acetylated Oligoglucuronans | GLA, OGA, CUTA | GPR84 1356/4885FFAR1 2758/4885MAPT 917/4885 |
| US-20120028916-A1 | COSMETIC COMPOSITIONS COMPRISING ORIDONIN AND NEW COSMETIC USES | DPM1, MC1R, SLTM | GPR84 2434/4885FFAR1 2328/4885MAPT 3453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.